Download PDF
CC BY-NC-ND 4.0 · South Asian J Cancer 2014; 03(02): 141
DOI: 10.4103/2278-330X.130469
Letters to Editor

Myeloma and diabetes mellitus

Sora Yasri
Primary Care Unit, KMT Center, Bangkok, Thailand
,
Viroj Wiwanitkit
Visiting Professor, Hainan Medical University, China
Visiting Professor, Faculty of Medicine, University of Nis, Serbia
› Author Affiliations
› Further Information
  PDF Download Permissions and Reprints


Publication History

Article published online:
31 December 2020

© 2014. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Ali MA, Ahmed YA, Ibrahim A. Clinical challenges: Myeloma and concomitant type 2 diabetes. South Asian J Cancer 2013;2:290-5.
  • 2 Ahmed YA, Eltayeb A. Clinical challenges: Myeloma and concomitant type 2 diabetes. Int J Hematol Oncol Stem Cell Res 2013;7:34-41.
  • 3 Pospísilová Y, Adam Z. Disorder of glucose metabolism regulation in patients with multiple myeloma treated with high doses of corticosteroids at our clinic in 2004. Vnitr Lek 2007;53:18-23.
  • 4 Snowden JA, Greaves M, Page K. Reversal of diabetes associated with escape of myeloma: Evidence for inappropriate IGF-II secretion. Br J Haematol 1994;87:202-4.